131 related articles for article (PubMed ID: 23560917)
1. Immune responses to baculovirus-displayed enterovirus 71 VP1 antigen.
Kiener TK; Premanand B; Kwang J
Expert Rev Vaccines; 2013 Apr; 12(4):357-64. PubMed ID: 23560917
[TBL] [Abstract][Full Text] [Related]
2. Induction of a high-titered antibody response using HIV gag-EV71 VP1-based virus-like particles with the capacity to protect newborn mice challenged with a lethal dose of enterovirus 71.
Wang X; Dong K; Long M; Lin F; Gao Z; Wang L; Zhang Z; Chen X; Dai Y; Wang H; Zhang H
Arch Virol; 2018 Jul; 163(7):1851-1861. PubMed ID: 29582164
[TBL] [Abstract][Full Text] [Related]
3. Oral immunization with recombinant enterovirus 71 VP1 formulated with chitosan protects mice against lethal challenge.
Zhang F; Hao C; Zhang S; Li A; Zhang Q; Wu W; Liu L; Li C; Liang M; Li X; Li D
Virol J; 2014 May; 11():80. PubMed ID: 24885121
[TBL] [Abstract][Full Text] [Related]
4. Oral immunization of mice using Bifidobacterium longum expressing VP1 protein from enterovirus 71.
Yu Z; Huang Z; Sao C; Huang Y; Zhang F; Ma G; Chen Z; Zeng Z; Qiwen D; Zeng W
Arch Virol; 2013 May; 158(5):1071-7. PubMed ID: 23275129
[TBL] [Abstract][Full Text] [Related]
5. Induction of protective immune responses against EV71 in mice by baculovirus encoding a novel expression cassette for capsid protein VP1.
Premanand B; Kiener TK; Meng T; Tan YR; Jia Q; Chow VT; Kwang J
Antiviral Res; 2012 Sep; 95(3):311-5. PubMed ID: 22691220
[TBL] [Abstract][Full Text] [Related]
6. Display of enterovirus 71 VP1 on baculovirus as a type II transmembrane protein elicits protective B and T cell responses in immunized mice.
Kolpe AB; Kiener TK; Grotenbreg GM; Kwang J
Virus Res; 2012 Sep; 168(1-2):64-72. PubMed ID: 22728446
[TBL] [Abstract][Full Text] [Related]
7. Protection against lethal enterovirus 71 infection in newborn mice by passive immunization with subunit VP1 vaccines and inactivated virus.
Wu CN; Lin YC; Fann C; Liao NS; Shih SR; Ho MS
Vaccine; 2001 Dec; 20(5-6):895-904. PubMed ID: 11738755
[TBL] [Abstract][Full Text] [Related]
8. [Study on adjuvant effect of oral recombinant subunit vaccine formulated with chitosan against human enterovirus 71].
Zhang S; Zhang FS; Li AQ; Liu L; Wu W; Li C; Zhang QF; Liang MF; Li DX
Bing Du Xue Bao; 2014 May; 30(3):221-5. PubMed ID: 25118374
[TBL] [Abstract][Full Text] [Related]
9. Baculovirus as a PRRSV and PCV2 bivalent vaccine vector: baculovirus virions displaying simultaneously GP5 glycoprotein of PRRSV and capsid protein of PCV2.
Xu XG; Wang ZS; Zhang Q; Li ZC; Ding L; Li W; Wu HY; Chang CD; Lee LH; Tong DW; Liu HJ
J Virol Methods; 2012 Feb; 179(2):359-66. PubMed ID: 22172969
[TBL] [Abstract][Full Text] [Related]
10. Update on the development of enterovirus 71 vaccines.
Kung YA; Hung CT; Liu YC; Shih SR
Expert Opin Biol Ther; 2014 Oct; 14(10):1455-64. PubMed ID: 24989170
[TBL] [Abstract][Full Text] [Related]
11. Recombinant baculovirus associated with bilosomes as an oral vaccine candidate against HEV71 infection in mice.
Premanand B; Prabakaran M; Kiener TK; Kwang J
PLoS One; 2013; 8(2):e55536. PubMed ID: 23390538
[TBL] [Abstract][Full Text] [Related]
12. Development of a low-cost, insect larvae-derived recombinant subunit vaccine against RHDV.
Pérez-Filgueira DM; Resino-Talaván P; Cubillos C; Angulo I; Barderas MG; Barcena J; Escribano JM
Virology; 2007 Aug; 364(2):422-30. PubMed ID: 17434554
[TBL] [Abstract][Full Text] [Related]
13. Expression and immunogenicity of novel subunit enterovirus 71 VP1 antigens.
Xu J; Wang S; Gan W; Zhang W; Ju L; Huang Z; Lu S
Biochem Biophys Res Commun; 2012 Apr; 420(4):755-61. PubMed ID: 22450314
[TBL] [Abstract][Full Text] [Related]
14. Partial protection against enterovirus 71 (EV71) infection in a mouse model immunized with recombinant Newcastle disease virus capsids displaying the EV71 VP1 fragment.
Ch'ng WC; Stanbridge EJ; Ong KC; Wong KT; Yusoff K; Shafee N
J Med Virol; 2011 Oct; 83(10):1783-91. PubMed ID: 21837796
[TBL] [Abstract][Full Text] [Related]
15. Comparison of vaccine efficacy for different antigen delivery systems for infectious pancreatic necrosis virus vaccines in Atlantic salmon (Salmo salar L.) in a cohabitation challenge model.
Munang'andu HM; Fredriksen BN; Mutoloki S; Brudeseth B; Kuo TY; Marjara IS; Dalmo RA; Evensen Ø
Vaccine; 2012 Jun; 30(27):4007-16. PubMed ID: 22537985
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the enterovirus 71 VP1 protein as a vaccine candidate.
Zhou SL; Ying XL; Han X; Sun XX; Jin Q; Yang F
J Med Virol; 2015 Feb; 87(2):256-62. PubMed ID: 25043151
[TBL] [Abstract][Full Text] [Related]
17. Recombinant VP1 protein expressed in Pichia pastoris induces protective immune responses against EV71 in mice.
Wang M; Jiang S; Wang Y
Biochem Biophys Res Commun; 2013 Jan; 430(1):387-93. PubMed ID: 23159634
[TBL] [Abstract][Full Text] [Related]
18. Pros and cons of VP1-specific maternal IgG for the protection of Enterovirus 71 infection.
Kim YI; Song JH; Kwon BE; Kim HN; Seo MD; Park K; Lee S; Yeo SG; Kweon MN; Ko HJ; Chang SY
Vaccine; 2015 Nov; 33(48):6604-10. PubMed ID: 26529069
[TBL] [Abstract][Full Text] [Related]
19. Expression of VP1 protein in the milk of transgenic mice: a potential oral vaccine protects against enterovirus 71 infection.
Chen HL; Huang JY; Chu TW; Tsai TC; Hung CM; Lin CC; Liu FC; Wang LC; Chen YJ; Lin MF; Chen CM
Vaccine; 2008 Jun; 26(23):2882-9. PubMed ID: 18450335
[TBL] [Abstract][Full Text] [Related]
20. Human Enterovirus 71 Protein Displayed on the Surface of Saccharomyces cerevisiae as an Oral Vaccine.
Zhang C; Wang Y; Ma S; Li L; Chen L; Yan H; Peng T
Viral Immunol; 2016 Jun; 29(5):288-95. PubMed ID: 27259043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
